Class IIOngoing
STRIDES PHARMA INC recalls Cinacalcet Tablets
Recall date · record updated Oct 28, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- STRIDES PHARMA INC
- Reason
- Failed dissolution specifications
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- US Nationwide
- Where
- Nationwide
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=100087…
Products
Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04
Codes/lots: Lot # 7717825A, Expiry: 11/30/2028.Quantity: 49,488 30-count bottlesRecall no. D-0079-2027Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass I
Par Health USA, LLC recalls 2 products
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
· FDA · Nationwide
Medicines & devicesClass II
Right Value Drug Stores LLC recalls Testosterone Cypionate
Lack of sterility assurance.
· FDA · Nationwide
Medicines & devicesClass II
Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
· FDA · Nationwide